Anúncio
Anúncio
MGX
Metagenomi, Inc. Common Stock
1.79
USDPatrocinado
+0.02
+1.41%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.77
-0.02
-1.11%
Relatórios de Lucros MGX
Rácio de surpresa positiva
MGX separação 6 de 8 últimas estimativas.
75%
Próximo Relatório
Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$6.81M
/-$0.61
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-21.33%
/+10.91%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-29.15%
/-3.17%
Metagenomi, Inc. Common Stock earnings per share and revenue
On 11 de nov. de 2025, MGX reported earnings of -0.55 USD per share (EPS) for Q3 25, beating the estimate of -0.58 USD, resulting in a 6.75% surprise. Revenue reached 8.66 milhão, compared to an expected 7.47 milhão, with a 15.85% difference. The market reacted with a -15.45% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.61 USD, with revenue projected to reach 6.81 milhão USD, implying an aumentar of 10.91% EPS, and diminuir of -21.33% in Revenue from the last quarter.
FAQ
What were Metagenomi, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Metagenomi, Inc. Common Stock reported EPS of -$0.55, beating estimates by 6.75%, and revenue of $8.66M, 15.85% above expectations.
How did the market react to Metagenomi, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -15.45%, changed from $2.20 before the earnings release to $1.86 the day after.
When is Metagenomi, Inc. Common Stock expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for Metagenomi, Inc. Common Stock's next earnings report?
Based on 6
analistas, Metagenomi, Inc. Common Stock is expected to report EPS of -$0.61 and revenue of $6.81M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio